| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0002 |
| mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.001 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.003 |
| mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.003 |
| mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.006 |
| mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.006 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.007 |